Suppr超能文献

结直肠癌根治性手术后结局的预测:术前血红蛋白、C 反应蛋白和白蛋白。

Prediction of outcome after curative surgery for colorectal cancer: preoperative haemoglobin, C-reactive protein and albumin.

机构信息

Center for Digestive Diseases, P9:03, Karolinska University Hospital, Solna, Sweden.

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

出版信息

Colorectal Dis. 2018 Jan;20(1):26-34. doi: 10.1111/codi.13807.

Abstract

AIM

The aim was to evaluate a scoring system using the values of preoperative haemoglobin, C-reactive protein (CRP) and albumin to predict colorectal cancer recurrence and survival.

METHOD

Data on all curative resections for Stages I-III colorectal cancer performed at a tertiary referral hospital in 2007-2010 were recorded in the Swedish Colorectal Cancer Registry and were matched to local databases for laboratory results and blood transfusion. Patients who died within 30 days or during primary hospital admission were excluded. Preoperative haemoglobin, CRP and albumin levels were recorded for 417 patients. A score (0-3) was derived on the presence of anaemia (Hb < 120 g/l for women and < 130 g/l for men), raised CRP (> 10 mg/ml) and low albumin (< 35 g/dl). The risks for recurrence and impaired overall survival were assessed using Cox regression analyses.

RESULTS

Impaired overall survival was found when one, two or three of the criteria anaemia, elevated CRP and low albumin were present prior to surgery [hazard ratio (HR) 3.61, 95% CI 1.66-7.85; HR 3.91, 95% CI 1.75-8.74; HR 4.85, 95% CI 2.15-10.93, respectively]. The risk for recurrence, however, was not related to the presence of these criteria.

CONCLUSION

Overall survival after curative surgery for Stages I-III colorectal cancer is impaired when anaemia, elevated CRP or low albumin exist prior to surgery.

摘要

目的

评估一种使用术前血红蛋白、C 反应蛋白(CRP)和白蛋白值的评分系统,以预测结直肠癌复发和生存。

方法

记录了 2007 年至 2010 年在一家三级转诊医院进行的 I-III 期结直肠癌根治性切除的所有数据,并与本地实验室结果和输血数据库相匹配。排除术后 30 天内或住院期间死亡的患者。记录了 417 例患者的术前血红蛋白、CRP 和白蛋白水平。根据是否存在贫血(女性血红蛋白 < 120g/l,男性血红蛋白 < 130g/l)、CRP 升高(> 10mg/ml)和低白蛋白血症(< 35g/dl),得出一个(0-3)分的评分。使用 Cox 回归分析评估复发和总生存不良的风险。

结果

术前存在贫血、CRP 升高和低白蛋白血症一个、两个或三个标准时,总生存不良(危险比[HR] 3.61,95%置信区间[CI] 1.66-7.85;HR 3.91,95% CI 1.75-8.74;HR 4.85,95% CI 2.15-10.93)。然而,复发风险与这些标准的存在无关。

结论

I-III 期结直肠癌根治术后,术前存在贫血、CRP 升高或低白蛋白血症时,总生存受损。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验